Silver Spike Investment Corp. (SSIC)

USD 10.74

(1.27%)

Operating Income Summary of Silver Spike Investment Corp.

  • Silver Spike Investment Corp.'s latest annual operating income in 2023 was 7.34 Million USD , up 270.44% from previous year.
  • Silver Spike Investment Corp.'s latest quarterly operating income in 2024 Q1 was 555.74 Million USD , up 22149.75% from previous quarter.
  • Silver Spike Investment Corp. reported an annual operating income of 1.98 Million USD in 2022, up 451.72% from previous year.
  • Silver Spike Investment Corp. reported an annual operating income of -563.36 Thousand USD in 2021, up 41.21% from previous year.
  • Silver Spike Investment Corp. reported a quarterly operating income of 2.35 Million USD for 2023 Q1, up 65.37% from previous quarter.
  • Silver Spike Investment Corp. reported a quarterly operating income of 2.49 Million USD for 2023 Q4, down -99.91% from previous quarter.

Annual Operating Income Chart of Silver Spike Investment Corp. (2023 - 2020)

Historical Annual Operating Income of Silver Spike Investment Corp. (2023 - 2020)

Year Operating Income Operating Income Growth
2023 7.34 Million USD 270.44%
2022 1.98 Million USD 451.72%
2021 -563.36 Thousand USD 41.21%
2020 -958.29 Thousand USD 0.0%

Peer Operating Income Comparison of Silver Spike Investment Corp.

Name Operating Income Operating Income Difference
Esperion Therapeutics, Inc. -155.56 Million USD 104.718%
Theratechnologies Inc. -10.62 Million USD 169.07%
Safety Shot Inc -12.18 Million USD 160.243%
Cosmos Health Inc. -21.83 Million USD 133.622%
Cronos Group Inc. -81.37 Million USD 109.02%
Ironwood Pharmaceuticals, Inc. 209.03 Million USD 96.489%
Kala Pharmaceuticals, Inc. -39.15 Million USD 118.747%
Organogenesis Holdings Inc. 12.52 Million USD 41.396%
Universe Pharmaceuticals INC -3.52 Million USD 308.125%
ProPhase Labs, Inc. -21.61 Million USD 133.962%
Sonoma Pharmaceuticals, Inc. -4.7 Million USD 256.139%
Dynavax Technologies Corporation -37.02 Million USD 119.823%
Radius Health, Inc. -3.92 Million USD 287.009%
China SXT Pharmaceuticals, Inc. -2.51 Million USD 391.828%
Alvotech -354.86 Million USD 102.068%
Sunshine Biopharma, Inc. -4.78 Million USD 253.389%
Alpha Teknova, Inc. -35.56 Million USD 120.64%
Intra-Cellular Therapies, Inc. -159.38 Million USD 104.605%
SCYNEXIS, Inc. 72.66 Million USD 89.899%
Harrow Health, Inc. 580 Thousand USD -1165.536%
Biofrontera Inc. -22.67 Million USD 132.368%
DURECT Corporation -36.88 Million USD 119.901%
Supernus Pharmaceuticals, Inc. -5.26 Million USD 239.307%
ANI Pharmaceuticals, Inc. 46.97 Million USD 84.373%
OptiNose, Inc. -22.74 Million USD 132.267%
RedHill Biopharma Ltd. 12.63 Million USD 41.893%
Aquestive Therapeutics, Inc. -15.1 Million USD 148.604%
Cumberland Pharmaceuticals Inc. -6.21 Million USD 218.183%
SIGA Technologies, Inc. 83.62 Million USD 91.222%
Lifecore Biomedical, Inc. 9.33 Million USD 21.336%
Shineco, Inc. -17.06 Million USD 143.01%
Phibro Animal Health Corporation 53.31 Million USD 86.233%
Procaps Group S.A. 52.32 Million USD 85.972%
TherapeuticsMD, Inc. -8.52 Million USD 186.121%
Regencell Bioscience Holdings Limited -4.73 Million USD 254.962%
Viatris Inc. 766.2 Million USD 99.042%
Sunshine Biopharma, Inc. -4.78 Million USD 253.389%
Rockwell Medical, Inc. -6.67 Million USD 210.047%
Incannex Healthcare Limited -30.04 Million USD 124.434%
Aytu BioPharma, Inc. -5.25 Million USD 239.705%
Tilray Brands, Inc. -174.74 Million USD 104.2%
Collegium Pharmaceutical, Inc. 166.96 Million USD 95.604%
PetIQ, Inc. 60.01 Million USD 87.77%
Neurocrine Biosciences, Inc. 250.9 Million USD 97.074%
Journey Medical Corporation -2.07 Million USD 454.082%
Alimera Sciences, Inc. -1.47 Million USD 598.988%
Petros Pharmaceuticals, Inc. -13.61 Million USD 153.903%
Assertio Holdings, Inc. -243.53 Million USD 103.014%
Shuttle Pharmaceuticals Holdings, Inc. -5.89 Million USD 224.57%
Embecta Corp. 221.5 Million USD 96.686%
Cyclo Therapeutics, Inc. -20.05 Million USD 136.609%
Procaps Group, S.A. 38.97 Million USD 81.166%
PainReform Ltd. -9.58 Million USD 176.587%
Avadel Pharmaceuticals plc -137.84 Million USD 105.325%
Hempacco Co., Inc. -8.81 Million USD 183.294%
Talphera, Inc. -16.88 Million USD 143.461%
Pacira BioSciences, Inc. 87.67 Million USD 91.628%
Alvotech -354.86 Million USD 102.068%
Lantheus Holdings, Inc. 364.64 Million USD 97.987%
Kamada Ltd. 10.06 Million USD 27.066%
Indivior PLC -4 Million USD 283.503%
Currenc Group, Inc. -6.64 Million USD 210.448%
Evoke Pharma, Inc. -7.43 Million USD 198.778%
Flora Growth Corp. -50.35 Million USD 114.577%
Cyclo Therapeutics, Inc. -20.05 Million USD 136.609%
Evolus, Inc. -49.23 Million USD 114.909%
HUTCHMED (China) Limited 18.37 Million USD 60.054%
Amphastar Pharmaceuticals, Inc. 196.98 Million USD 96.274%
Akanda Corp. -10.05 Million USD 173.026%